WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 352

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 105  104  104  104  104  107  96  73 
Births
Surviving infants
Pop. less than 5 years 12  12  12  12  12  15  15  13 
Pop. less than 15 years 35  36  36  36  37  43  42  35 
Female 15-49 years 26  26  26  25  25  27  22  15 

Number of reported cases

(Click for retrospective incidence data for Micronesia (Federated States of))
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  140 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Micronesia (Federated States of))
Vaccine year result method % card seen                                                
BCG          85  76  89  70  78  24  12 
DTP1          95  95  94  98  97  95 
DTP3          69  72  78  81  81  85  85 
DTP4          43  76  58 
IPV1          95  95 
HepB_BD          80  76  86  69  81  65 
HepB3          76  78  81  83  82  87 
Hib3          46  61  65  68  66  75 
JapEnc         
MCV1          70  74  94  91  91  85  81 
MCV2          45  74  78  75  70  50 
MenA         
PCV1          94  92  88  92  92 
PCV2          80  79  76  79  77 
PCV3          63  67  56  61  60 
Pol3          68  70  78  81  81  85  85 
Rota1          64  46  56  59  59 
RotaC          35  46  45  33  45 
RCV1          70  74  94  91  91 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Micronesia (Federated States of))
BCG
ChartChart
  85  76  73  70  78  24  12 
DTP1
ChartChart
  95  95  97  98  97  92  95 
DTP3
ChartChart
  69  72  77  81  81  85  85 
HepB3
ChartChart
  76  78  81  83  82  87  56 
HepB_BD
ChartChart
  80  75  72  69  81  65 
Hib3
ChartChart
  61  61  65  68  66  75 
MCV1
ChartChart
  70  74  83  91  91  85  81 
MCV2
ChartChart
  74  74  75  75  70  50 
PCV3
ChartChart
  63  67  64  61  60 
Pol3
ChartChart
  68  71  76  81  81  85  85 
RCV1
ChartChart
  70  74  83  91  91  85  81 
RotaC
ChartChart
  46  46  40  33  45 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 25
From 50 to 79% 25
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 12 months; 4 years; Yes
DTaPHepIPV 2, 4, 6 months; Yes
HepB_Pediatric birth; Yes
Hib 2, 6, 12 months; Yes
HPV 9 years; +2, +6 months; Yes
Influenza_Adult Yes eligible persons and chronic illness, pregnant women, health care workers
Influenza_Pediatric >= 6 months; Yes and children with chronic disease
IPV >= 4 years; Yes
MMR 12, +13 months; Yes
Pneumo_conj 2, 4, 6, 13 months; Yes
Pneumo_ps >= 50 Years; Yes
Rotavirus 2, 4, 6 months; Yes
Td >=11 years; Yes
Tdap >=11 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2013-2017  2013-2017  2013-2017  2008-2013  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 75  75  75  75  75  75  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 25  50  25  50  25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  NA  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  Yes  Yes  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%         NA   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.